EichorEICHOR
Location: Kettering Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Kettering

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Hav
Phase 3 · Pfizer · NCT05020236A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Phase 1 · Erasca, Inc. · NCT06983743A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive
Phase 2 · Memorial Sloan Kettering Cancer Center · NCT07359859A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Eli Lilly and Company · NCT07218380Enhanced Pain Coping in Cancer (EPIC): A Study of Managing Treatment-Related Joint Pain in Breast Cancer Survivors
Phase 2 · Memorial Sloan Kettering Cancer Center · NCT06728579This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Pfizer · NCT07028853N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma
Phase 2 · Memorial Sloan Kettering Cancer Center · NCT06528496Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Bristol-Myers Squibb · NCT07106762A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma
Phase 2 · Sarcoma Alliance for Research through Collaboration · NCT06942442A Registry for People With T-cell Lymphoma
Phase N/A · Memorial Sloan Kettering Cancer Center · NCT05978141Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Merck Sharp & Dohme LLC · NCT06393374MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · National Cancer Institute (NCI) · NCT05564390A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · National Cancer Institute (NCI) · NCT05099003Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
Phase N/A · AIDS Malignancy Consortium · NCT05663502Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Can
Phase 2 · Aadi Bioscience, Inc. · NCT05997017Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · NRG Oncology · NCT05624996A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Phase 1 · Pfizer · NCT07206225COLO-COHORT (Colorectal Cancer Cohort) Study
Phase N/A · Kettering General Hospitals NHS Foundation Trust · South Tyneside and Sunderland NHS Foundation Trust · NCT04185779A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Appr
Phase 2 · Memorial Sloan Kettering Cancer Center · NCT05534438A Study of Tucatinib and Trastuzumab in People With Rectal Cancer
Phase 2 · Memorial Sloan Kettering Cancer Center · NCT05672524A Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before Surgery
NA · Memorial Sloan Kettering Cancer Center · NCT06127979A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer
Phase 1 · Memorial Sloan Kettering Cancer Center · NCT06623396A Study of a Distress Screening and Referral Program in People With Recently Diagnosed Cancer
NA · Memorial Sloan Kettering Cancer Center · NCT07117461A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma
Phase 2 · Memorial Sloan Kettering Cancer Center · NCT06594991Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Phase 3 · PedAL BCU, LLC · NCT05183035A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Phase 2 · Children's Oncology Group · NCT06368817A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer
Phase 1 · Memorial Sloan Kettering Cancer Center · NCT06807632A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer
Phase 2 · City of Hope Medical Center · NCT05751434A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia
Phase 1 · Memorial Sloan Kettering Cancer Center · NCT07011004Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: RO
Phase 2 · Memorial Sloan Kettering Cancer Center · NCT01639508
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.